Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharm Res ; 18(4): 537-43, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11451043

RESUMO

PURPOSE: A population pharmacokinetic-pharmacodynamic model accounting for placebo effect was used to relate nicotine concentration and enforced smoking cessation craving score measured by the Tiffany rating scale short form. METHODS: Twenty-four smokers were enrolled in a placebo-controlled, randomized, double-blind, three periods, crossover trial. The study objective was to describe the nicotine-induced changes on craving scores. Two modeling strategies based on a mechanistic (indirect response models with drug-related inhibition on the k(in) synthesis rate and with a drug-related stimulation of the k(out) removal rate were evaluated) and a probabilistic (logistic regression) approach were used. RESULTS: Placebo response model properly fitted the circadian changes on craving scores. The analysis revealed that the indirect response model with inhibition on k(in) was the preferred model for the smoking data whereas the preferred model for the Nicotine Replacement Therapy data was the one with stimulation on k(out). The logistic analysis showed that the nicotine concentration was a significant predictor of reduction in craving during the free-smoking period. CONCLUSIONS: Nicotine dosage regimen can influence the nicotine mechanism of action: an instantaneous delivery at an individually selected time seems to inhibit the onset of craving while constant delivery at a pre-defined time seems to attenuate the craving.


Assuntos
Comportamento Aditivo/psicologia , Modelos Psicológicos , Modelos Estatísticos , Nicotina/farmacocinética , Agonistas Nicotínicos/farmacocinética , Abandono do Hábito de Fumar/estatística & dados numéricos , Adulto , Comportamento Aditivo/tratamento farmacológico , Estudos Cross-Over , Método Duplo-Cego , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Nicotina/uso terapêutico , Agonistas Nicotínicos/uso terapêutico , Saliva/metabolismo , Abandono do Hábito de Fumar/métodos , Abandono do Hábito de Fumar/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...